Abstract
Summary
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
The global market for Muscle Relaxers was estimated to be worth US$ 3900 million in 2023 and is forecast to a readjusted size of US$ 5754.8 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Muscle Relaxers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Muscle Relaxers by region & country, by Type, and by Application.
The Muscle Relaxers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle Relaxers.
Market Segmentation
By Company
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Segment by Type:
Tablet
Capsule
Segment by Application
Hospital
Clinic
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Muscle Relaxers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Muscle Relaxers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Muscle Relaxers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Muscle Relaxers was estimated to be worth US$ 3900 million in 2023 and is forecast to a readjusted size of US$ 5754.8 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Muscle Relaxers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Muscle Relaxers by region & country, by Type, and by Application.
The Muscle Relaxers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle Relaxers.
Market Segmentation
By Company
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Segment by Type:
Tablet
Capsule
Segment by Application
Hospital
Clinic
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Muscle Relaxers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Muscle Relaxers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Muscle Relaxers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Muscle Relaxers Product Introduction
1.2 Global Muscle Relaxers Market Size Forecast
1.2.1 Global Muscle Relaxers Sales Value (2019-2030)
1.2.2 Global Muscle Relaxers Sales Volume (2019-2030)
1.2.3 Global Muscle Relaxers Sales Price (2019-2030)
1.3 Muscle Relaxers Market Trends & Drivers
1.3.1 Muscle Relaxers Industry Trends
1.3.2 Muscle Relaxers Market Drivers & Opportunity
1.3.3 Muscle Relaxers Market Challenges
1.3.4 Muscle Relaxers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Muscle Relaxers Players Revenue Ranking (2023)
2.2 Global Muscle Relaxers Revenue by Company (2019-2024)
2.3 Global Muscle Relaxers Players Sales Volume Ranking (2023)
2.4 Global Muscle Relaxers Sales Volume by Company Players (2019-2024)
2.5 Global Muscle Relaxers Average Price by Company (2019-2024)
2.6 Key Manufacturers Muscle Relaxers Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Muscle Relaxers Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Muscle Relaxers
2.9 Muscle Relaxers Market Competitive Analysis
2.9.1 Muscle Relaxers Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Muscle Relaxers Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Capsule
3.2 Global Muscle Relaxers Sales Value by Type
3.2.1 Global Muscle Relaxers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Muscle Relaxers Sales Value, by Type (2019-2030)
3.2.3 Global Muscle Relaxers Sales Value, by Type (%) (2019-2030)
3.3 Global Muscle Relaxers Sales Volume by Type
3.3.1 Global Muscle Relaxers Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Muscle Relaxers Sales Volume, by Type (2019-2030)
3.3.3 Global Muscle Relaxers Sales Volume, by Type (%) (2019-2030)
3.4 Global Muscle Relaxers Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Pharmacy
4.2 Global Muscle Relaxers Sales Value by Application
4.2.1 Global Muscle Relaxers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Muscle Relaxers Sales Value, by Application (2019-2030)
4.2.3 Global Muscle Relaxers Sales Value, by Application (%) (2019-2030)
4.3 Global Muscle Relaxers Sales Volume by Application
4.3.1 Global Muscle Relaxers Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Muscle Relaxers Sales Volume, by Application (2019-2030)
4.3.3 Global Muscle Relaxers Sales Volume, by Application (%) (2019-2030)
4.4 Global Muscle Relaxers Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Muscle Relaxers Sales Value by Region
5.1.1 Global Muscle Relaxers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Muscle Relaxers Sales Value by Region (2019-2024)
5.1.3 Global Muscle Relaxers Sales Value by Region (2025-2030)
5.1.4 Global Muscle Relaxers Sales Value by Region (%), (2019-2030)
5.2 Global Muscle Relaxers Sales Volume by Region
5.2.1 Global Muscle Relaxers Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Muscle Relaxers Sales Volume by Region (2019-2024)
5.2.3 Global Muscle Relaxers Sales Volume by Region (2025-2030)
5.2.4 Global Muscle Relaxers Sales Volume by Region (%), (2019-2030)
5.3 Global Muscle Relaxers Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Muscle Relaxers Sales Value, 2019-2030
5.4.2 North America Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Muscle Relaxers Sales Value, 2019-2030
5.5.2 Europe Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Muscle Relaxers Sales Value, 2019-2030
5.6.2 Asia Pacific Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Muscle Relaxers Sales Value, 2019-2030
5.7.2 South America Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Muscle Relaxers Sales Value, 2019-2030
5.8.2 Middle East & Africa Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Muscle Relaxers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Muscle Relaxers Sales Value
6.2.1 Key Countries/Regions Muscle Relaxers Sales Value, 2019-2030
6.2.2 Key Countries/Regions Muscle Relaxers Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Muscle Relaxers Sales Value, 2019-2030
6.3.2 United States Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Muscle Relaxers Sales Value, 2019-2030
6.4.2 Europe Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Muscle Relaxers Sales Value, 2019-2030
6.5.2 China Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Muscle Relaxers Sales Value, 2019-2030
6.6.2 Japan Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Muscle Relaxers Sales Value, 2019-2030
6.7.2 South Korea Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Muscle Relaxers Sales Value, 2019-2030
6.8.2 Southeast Asia Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Muscle Relaxers Sales Value, 2019-2030
6.9.2 India Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Muscle Relaxers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novartis Muscle Relaxers Product Offerings
7.1.5 Novartis Recent Development
7.2 Viatris
7.2.1 Viatris Company Information
7.2.2 Viatris Introduction and Business Overview
7.2.3 Viatris Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Viatris Muscle Relaxers Product Offerings
7.2.5 Viatris Recent Development
7.3 Teva Pharmaceuticals
7.3.1 Teva Pharmaceuticals Company Information
7.3.2 Teva Pharmaceuticals Introduction and Business Overview
7.3.3 Teva Pharmaceuticals Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Teva Pharmaceuticals Muscle Relaxers Product Offerings
7.3.5 Teva Pharmaceuticals Recent Development
7.4 Endo Pharmaceuticals
7.4.1 Endo Pharmaceuticals Company Information
7.4.2 Endo Pharmaceuticals Introduction and Business Overview
7.4.3 Endo Pharmaceuticals Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Endo Pharmaceuticals Muscle Relaxers Product Offerings
7.4.5 Endo Pharmaceuticals Recent Development
7.5 Mayne Pharma
7.5.1 Mayne Pharma Company Information
7.5.2 Mayne Pharma Introduction and Business Overview
7.5.3 Mayne Pharma Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mayne Pharma Muscle Relaxers Product Offerings
7.5.5 Mayne Pharma Recent Development
7.6 Merck & Co. Inc
7.6.1 Merck & Co. Inc Company Information
7.6.2 Merck & Co. Inc Introduction and Business Overview
7.6.3 Merck & Co. Inc Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck & Co. Inc Muscle Relaxers Product Offerings
7.6.5 Merck & Co. Inc Recent Development
7.7 GSK
7.7.1 GSK Company Information
7.7.2 GSK Introduction and Business Overview
7.7.3 GSK Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GSK Muscle Relaxers Product Offerings
7.7.5 GSK Recent Development
7.8 Casper Pharma LLC
7.8.1 Casper Pharma LLC Company Information
7.8.2 Casper Pharma LLC Introduction and Business Overview
7.8.3 Casper Pharma LLC Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Casper Pharma LLC Muscle Relaxers Product Offerings
7.8.5 Casper Pharma LLC Recent Development
7.9 Bayer
7.9.1 Bayer Company Information
7.9.2 Bayer Introduction and Business Overview
7.9.3 Bayer Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bayer Muscle Relaxers Product Offerings
7.9.5 Bayer Recent Development
7.10 BASF
7.10.1 BASF Company Information
7.10.2 BASF Introduction and Business Overview
7.10.3 BASF Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.10.4 BASF Muscle Relaxers Product Offerings
7.10.5 BASF Recent Development
7.11 ADVIL
7.11.1 ADVIL Company Information
7.11.2 ADVIL Introduction and Business Overview
7.11.3 ADVIL Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.11.4 ADVIL Muscle Relaxers Product Offerings
7.11.5 ADVIL Recent Development
7.12 Pfizer
7.12.1 Pfizer Company Information
7.12.2 Pfizer Introduction and Business Overview
7.12.3 Pfizer Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Pfizer Muscle Relaxers Product Offerings
7.12.5 Pfizer Recent Development
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Company Information
7.13.2 Johnson & Johnson Introduction and Business Overview
7.13.3 Johnson & Johnson Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Johnson & Johnson Muscle Relaxers Product Offerings
7.13.5 Johnson & Johnson Recent Development
7.14 Rosemont Pharmaceuticals
7.14.1 Rosemont Pharmaceuticals Company Information
7.14.2 Rosemont Pharmaceuticals Introduction and Business Overview
7.14.3 Rosemont Pharmaceuticals Muscle Relaxers Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Rosemont Pharmaceuticals Muscle Relaxers Product Offerings
7.14.5 Rosemont Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Muscle Relaxers Industrial Chain
8.2 Muscle Relaxers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Muscle Relaxers Sales Model
8.5.2 Sales Channel
8.5.3 Muscle Relaxers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer